During the past decade, Baskent Universitesi Ankara Hastanesi; Noroloji Bolumu conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Baskent Universitesi Ankara Hastanesi; Noroloji Bolumu" are "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "Baskent Universitesi Ankara Hastanesi; Noroloji Bolumu" in a lesser frequency.

Most popular intervention types in "Baskent Universitesi Ankara Hastanesi; Noroloji Bolumu" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "Antihistamine" (1 trials), "Fenebrutinib" (1 trials), "Methylprednisolone" (1 trials) and "Placebo matched to fenebrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baskent Universitesi Ankara Hastanesi; Noroloji Bolumu" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Baskent Universitesi Ankara Hastanesi; Noroloji Bolumu". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Baskent Universitesi Ankara Hastanesi; Noroloji Bolumu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baskent Universitesi Ankara Hastanesi; Noroloji Bolumu, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".